MedTrace Logo

A Cross-sectional, Observational Multicenter Study to Assess the Reasons for Choosing the 3-year Hormonal IUD and Level of IUDs Knowledge Among Women Aged 18 to 29 Years

NCT02903888 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 886

Last updated 2018-01-12

No results posted yet for this study

Summary

A cross-sectional, observational multicenter study to assess the reasons for choosing the 3-year hormonal IUD and level of IUDs knowledge among women aged 18 to 29 years. The study will be conducted in standard clinical practice conditions at public and private gynecology clinics and during a single study visit.

Approximately 1,000 women aged 18 to 29 years who have freely chosen the 3 year hormonal IUD as their contraceptive method will be included in the study.

Conditions

  • Intrauterine Devices, Medicated

Interventions

DRUG

Levonorgestrel (Jaydess, Skyla, BAY86-5028)

Intrauterine delivery system Jaydess (13.5 mg levonorgestrel)

Sponsors & Collaborators

Principal Investigators

  • Bayer Study Director · Bayer

Eligibility

Min Age
18 Years
Max Age
29 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-09-08
Primary Completion
2017-10-30
Completion
2017-12-23

Countries

  • Spain

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02903888 on ClinicalTrials.gov